ABBOTT LABORATORIES T.ABT

Primary Symbol: ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

NYSE:ABT - Post by User

ABBOTT LABORATORIES

Bullboard Posts

Comment by beckalodeonon Jan 30, 2008 9:29pm

591 Views

Post# 14293744

RE: RBC Report - Reiterates $23 Target

Oh, and before someone asks me: that RBC CM report came out on January 14th. BTW, I just noticed that Peter Hodson is on BNN's Market Call on Thursday. I would be very surprised if he doesn't discuss ABT, as his Sprott Growth fund is a big ABT shareholder. Come to that, given the recent pummeling of its shares, it would hardly be shocking if he made Absolute a top pick again. After all, he said that during the August swoon he was buying hand-over-fist at a split-adjusted 11 bucks. It will be interesting to hear his comments about the firm's current prospects. - beck

Bullboard Posts

Quebecor achieves all Freedom Mobile acquisition commitments